Bulletin
Investor Alert

Market Pulse Archives

Dec. 4, 2019, 3:25 p.m. EST

Allakos stock jumps in afternoon trading

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Allakos Inc. (ALLK)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Allakos Inc. /zigman2/quotes/203639566/composite ALLK -0.40% rallied 37% in afternoon trading, to a record high. Sources told Bloomberg that the Redwood, Calif.-based biopharmaceutical company, which went public in August, is considering a sale. Allakos is in the early stages of developing treatments for eosinophilic gastritis and allergic conjunctivitis, among others. The rally has added roughly $1.7 billion to the company's market capitalization, to boost the market cap to about $6.4 billion. The company has not immediately responded to a request for comment. Allakos stock is up 146% year-to-date. The S&P 500 /zigman2/quotes/210599714/realtime SPX +1.05% has gained 24%.

/zigman2/quotes/203639566/composite
US : U.S.: Nasdaq
$ 7.40
-0.03 -0.40%
Volume: 577,328
Feb. 1, 2023 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$633.06 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,119.21
+42.61 +1.05%
Volume: 0.00
Feb. 1, 2023 4:53p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.